WII 2001
Alternative Names: WII-2001Latest Information Update: 09 Aug 2021
Price :
$50 *
At a glance
- Originator Whanin Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 21 Jul 2021 WII 2001 is available for licensing as of 19 Jul 2021. https://www.whanin.com/_commonBase/content.php?co_id=outlicense_kor# (Whanin Pharmaceutical website, July 2021)
- 19 Jul 2021 Early research in Cancer in South Korea (unspecified route) before July 2021 (Whanin Pharmaceutical pipeline, July 2021)